Scworx Corp (WORX) skyrockets on COVID-19 testing kit purchase order
Scworx Corp (WORX) currently trades at $10.15 and has grown by 351.55% today. WORX went up $7.91 from the previous closing price of $2.29. The high forecast for Scworx Corp is $25.00 and the low is $3.00. The company’s market cap is $70.50 million with a 52 week high of $11.75 and a 52 week low of $1.55. WORX has changed in price by 2.74 per share in the last 12 months. The company announced that it has received a purchase order for 2M COVID-19 Rapid Testing Kits from virtual healthcare network Rethink My Healthcare with a provision for additional orders of 2M units a week for 23 weeks (valued at $35M per week).
Scworx Corp has a weak EPS of -1.27. This means the company lost $-1.27 per share after paying dividends, this can indicate that the stock is a risky investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 5 out of 10. We give it this rating based on current information written in this article.
About Scworx Corp:
SCWorx Corp. provides software solutions. The Company offers an application that enables data normalization, application interoperability, and big data analytics within the healthcare provider market. SCWorx serves customers in the State of New York.